3SBio Inc
HKEX:1530
3SBio Inc
Cash from Operating Activities
3SBio Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
3SBio Inc
HKEX:1530
|
Cash from Operating Activities
¥2.3B
|
CAGR 3-Years
20%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Cash from Operating Activities
-¥7.8B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Cash from Operating Activities
-¥1.7B
|
CAGR 3-Years
-78%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash from Operating Activities
¥1.5B
|
CAGR 3-Years
49%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash from Operating Activities
¥3.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
106%
|
CAGR 10-Years
47%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Cash from Operating Activities
¥1.2B
|
CAGR 3-Years
57%
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
See Also
What is 3SBio Inc's Cash from Operating Activities?
Cash from Operating Activities
2.3B
CNY
Based on the financial report for Dec 31, 2023, 3SBio Inc's Cash from Operating Activities amounts to 2.3B CNY.
What is 3SBio Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
15%
Over the last year, the Cash from Operating Activities growth was 7%. The average annual Cash from Operating Activities growth rates for 3SBio Inc have been 20% over the past three years , 15% over the past five years .